Content uploaded by Ramin Sadeghi
Author content
All content in this area was uploaded by Ramin Sadeghi on Jul 25, 2014
Content may be subject to copyright.
* Corresponding author: Ramin Sadeghi, Nuclear Medicine Research Center, Mashhad University of Medical
Sciences, Mashhad, Iran. Tel: +985118012202; Fax: +985118933186; Email: sadeghir@mums.ac.ir;
raminsadeghi1355@yahoo.com
© 2014 mums.ac.ir All rights reserved.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
InappropriateIntra‐cervicalInjectionofRadiotracerfor
SentinelLymphNodeMappinginaUterineCervixCancer
Patient:ImportanceofLymphoscintigraphyandBlueDye
Injection
SimaKadkhodayan1,ElhamHosseiniFarahabadi1,ZohrehYousefi1,Malihe
Hasanzadeh1,RaminSadeghi2*
1 Women’sHealthResearchCenter,MashhadUniversityofMedicalSciences,Mashhad,Iran
2 NuclearMedicineResearchCenter,MashhadUniversityofMedicalSciences,Mashhad,Iran
ARTICLEINFOABSTRACT
Articletype:
Casereport
Herein,wereportacaseofsentinellymphnodemappinginauterine cervix cancer
patient, referring to the nuclear medicine department of our institute.
Lymphoscintigraphy images showed inappropriate intra‐cervical injection of
radiotracer.Bluedye techniquewasapplied for sentinellymph node mapping,using
intra‐cervicalinjectionof methyleneblue. Two blue/coldsentinel lymphnodes,with
no pathological involvement, were intra‐operatively identified,andthepatientwas
sparedpelviclymphnodedissection.Thepresentcaseunderscorestheimportanceof
lymphoscintigraphy imaging in sentinel lymph node mapping and demonstrates the
added value of blue dye injection in selected patients. It is suggested that pre‐
operative lymphoscintigraphy imaging be considered as an integral part of sentinel
lymph node mapping in surgical oncology. Detailed results of lymphoscintigraphy
imagesshouldbeprovidedforsurgeonspriortosurgery,andin case the sentinel
lymphnodes arenot visualized,use ofblue dyefor sentinelnodemappingshouldbe
encouraged.
Articlehistory:
Received:7Mar2014
Revised:2Apr2014
Accepted:15May2014
Keywords:
99mTc‐Phytate
Cervicalcancer
Lymphoscintigraphy
Methyleneblue
Sentinelnode
►Pleasecitethispaperas:
Kadkhodayan S, Hosseini FarahabadiE,YousefiZ,HasanzadehM,Sadeghi R. Inappropriate Intra‐cervical Injection of
RadiotracerforSentinelLymphNode Mappingin aUterineCervix CancerPatient: Importanceof Lymphoscintigraphy
andBlueDyeInjection.AsiaOceaniaJNuclMedBiol.2014;2(2):
Introduction
Sentinelnodemapping,asausefulmethod
for regional lymph node staging, minimizes the
morbidity associated with lymph node
dissectioninpatientswithsolidtumors.
Theconceptof sentinelnodemapping relies
on an orderly and predictable pattern of
lymphaticflowfromtumors.Sentinelnodesare
thefirstlymphnodesin thelymphaticdrainage
system of tumors, and can be considered as
surrogates for regional lymph nodes, regarding
thepathologicalinvolvement(1,2).
Two conventional methods for sentinel
lymphnodemappingareinjectionofradiotracer
andbluedye. Acombinationof radiotracerand
bluedyeinjectionforlymphaticmappingis
found to increase the detection rate and
decreasethefalse‐negativerateofsentinelnode
biopsy(3).However,severalauthorshave
proposedamorerestricteduseofbluedye
injection due to potential life‐threatening
complications, associated with this method (4‐
6).
Casereport
A 56‐year‐old female patient with a
histologically proven squamous cell carcinoma
(2 cm in diameter) of uterine cervix was
scheduled for sentinel node mapping in the
K
adkhoda
y
Page Num
b
Figure1.
E
the patien
t
(bluelarg
e
Figure2.
imagesof
t
theinjecti
o
nuclear
The pa
t
hystere
c
oophor
e
Eigh
t
patient
r
99mTc‐
P
mCi
/
Lympho
posterio
min af
t
variable
‐
as previ
was eq
u
collimat
o
photope
thehue
o
Lym
p
improp
e
as most
vagina (
seenon
t
y
an S et al
b
e
r
E
arlylymphosci
t
’s hue in the l
o
e
arrows).Nose
n
Delayed anter
t
hepatient.No
s
o
nsitesinthec
e
medicine d
e
t
ient was
p
c
tomy an
d
e
ctomy.
t
een hours
r
eceived tw
o
P
hytate at 3
/
0.1 cc
scintigraphy
r and later
a
t
er the inj
e
‐
anglegam
m
ously specifi
u
ipped with
o
r and ima
g
akandscatt
e
o
fthepatien
t
p
hoscintigra
p
e
r injection
o
oftheradi
o
Figure1);a
l
t
helymphos
c
ntigraphyimag
e
o
wer row. Note
n
tinelnodecoul
ior/posterior l
y
s
entinelnodeis
e
rvix
e
partment o
f
p
lanned to
d
bilater
a
before the
o
intra‐cervi
c
and 9 o’clo
c
for eac
h
images
w
a
l views we
r
e
ction, usin
g
m
acamera(E
C
ed (7). The
g
low‐energy
h
g
es were t
a
e
rphotopea
k
t
)(1image/
5
p
hy ima
g
o
f radiotrace
r
o
activity wa
s
l
so, no senti
n
c
intigraphyi
m
e
softhepatient
.
minimal activit
y
dbevisualized
i
y
mphoscintigra
p
visible.Arrows
f
ourinstit
u
undergo to
a
l salpin
g
surgery,
t
c
alinjections
c
k positions
h
injectio
n
w
ith anteri
o
r
e obtained
g
adual‐h
e
C
AM,Sieme
n
g
amma cam
e
h
igh‐resoluti
a
ken by 99
m
k
s(forimagi
5
min).
g
es sho
w
r
inthecer
v
s
visible in
t
n
el nodes w
e
m
ages.
.
Theoriginali
m
y
in the cervix
(
i
nthepelvis
p
hy
are
u
te.
tal
g
o‐
t
he
of
(1
n
).
o
r‐
30
e
ad
n
s),
e
ra
on
m
Tc
ng
w
ed
v
ix,
t
he
e
re
r
a
l
y
s
a
l
y
t
w
(
0
p
e
F
r
i
n
r
e
d
e
e
x
f
o
l
y
D
s
e
b
y
b
e
n
e
i
n
s
e
w
a
n
s
o
u
s
I
n
t
h
b
r
e
x
m
agesareshow
n
(
black arrows)
a
The patie
n
a
diotracer
y
mphoscintig
a
me finding
y
mph nodes
w
o intra‐cer
v
0
.5 cc/inject
i
e
rformedus
i
r
ance)andb
l
Two blu
e
n
tra‐operativ
e
e
gions. How
e
e
tected by t
h
x
amination
o
o
r pathologi
c
y
mphnoded
i
D
iscussion
The impo
r
e
ntinel node
y
manyre
s
e
hind blue d
e
gative rate
n
crease the
e
ntinelnode
s
However,
a
w
ith some
n
aphylactic
o
me authors
s
e of blue d
y
n
animport
a
h
atthemarg
i
r
east canc
e
x
perience of
L
ymphosci
n
A
sia Oceania
n
intheupperro
a
nd extension
o
n
t refused to
injectio
n
raphy imag
e
s without
(Figure 2).
v
ical injectio
n
i
on), and ly
m
i
ngagamm
a
l
uedyetech
n
e
sentineln
o
e
ly in the ri
g
e
ver, no hot
h
e gamma
p
o
fthesentin
e
c
al involve
m
i
ssectionwa
s
r
tance of bl
u
mapping h
a
s
earchers (
5
ye techniqu
e
of sentinel
intra‐ope
r
s
.
a
ddition of
b
risks inclu
d
reactions (
6
have propo
s
y
e in sentine
a
nt study, D
e
i
nalbenefito
e
r patients
surgeons in
c
n
tigraphy in Cer
v
J Nucl Med Bio
l
.
wandthescatt
e
o
f radiotracer i
n
undergo an
n
. Pre‐
o
e
s also sh
o
any visible
The patient
n
s of methy
l
m
phatic map
p
a
probe(EU
R
n
ique.
o
des were
i
g
htandleft
o
sentinel no
d
p
robe. Froze
n
e
lnodeswas
m
ent, and
n
s
performed.
u
e dye tec
h
a
s been dem
o
5
, 8). The
e
istodecre
a
node map
p
r
ative dete
c
b
lue dye is a
d
ing life‐th
r
6
, 9, 10).
T
s
ed a more
r
l node map
p
e
rossis et al.
fbluedyein
j
decreases
c
reases (12)
.
v
ical Cance
r
2014; 2(2):
e
rogramsof
n
thevagina
y further
o
perative
o
wed the
sentinel
received
l
ene blue
p
ing was
R
OPROBE,
i
dentified
o
bturator
d
es were
n
section
negative
n
o pelvic
h
nique in
o
nstrated
rationale
a
se false‐
p
ing and
c
tion of
ssociated
r
eatening
T
herefore,
r
estricted
p
ing (11).
reported
j
ectionin
as the
.
Another
Lymphoscintigraphy in Cervical Cancer Kadkhodayan S et al
Asia Oceania J Nucl Med Biol. 2014; 2(2): Page Number
studybySadeghietal.reportedsimilarfindings,
and showed the marginal benefits of blue dye
technique in case of sentinel node visualization
onlymphoscintigraphyimages(4).
The present case shows the importance of
lymphoscintigraphy imaging as an integral part
of sentinel node mapping. Lymphoscintigraphy
imagesindicatedtheinappropriateinjectionof
radiotracer(inour case,failureto injecttheair
bubblebehindtheradiotracerinsyringes),and
the surgeon was informed about the results
beforethesurgery.Bluedyetechniquewas
successful for lymphatic mapping and the
patient was spared pelvic lymph node
dissection.
Therefore, non‐visualization of sentinel
nodesonlymphoscintigraphy imagesshouldbe
reportedtosurgicaloncologists,anduseofblue
dye technique should be promoted in similar
clinicalsituations.
References
1. TarjanM.Sentinellymphnodebiopsyin
Hungary. Results with a revolutionary new
method in surgical oncology. Magy Onkol.
2002;46(4):315‐21.
2. Ellis LM. A perspective on sentinel lymph node
biopsyincolorectalcancer:theracebetween
surgicaltechnologyandmolecularoncology.Ann
SurgOncol.2000;7(7):475‐6.
3. SnojM, GolouhR, Movrin‐StanovnikT,Vidergar‐
KraljB. Addedvalueof bluedyeinsentinelnode
biopsyforbreastcancer.JExpClinCancerRes.
2003;22(4):551‐5.
4. Sadeghi R, Alesheikh G, Zakavi SR, Fattahi A,
AbdollahiA,AssadiM,etal.Added valueof blue
dye injection in sentinel node biopsy of breast
cancer patients: Do all patients need blue dye?.
IntJSurg.2014;12(4):325‐8.
5. Ramin S, Azar FP, Malihe H. Methylene blue as
thesafestbluedyeforsentinelnodemapping:
emphasis on anaphylaxis reaction. Acta Oncol.
2011;50(5):729‐31.
6. Jangjoo A, Forghani MN, Mehrabibahar M,
SadeghiR.Anaphylaxisreactionofabreast
cancer patient to methylene blue during breast
surgerywith sentinelnode mapping.Acta Oncol.
2010;49(6):877‐8.
7. MomennezhadM,ZakaviSR,DabbaghKakhkiVR,
Jangjoo A, Ghavamnasiri MR, Sadeghi R.
Scatterogram: a method for outlining the body
during lymphoscintigraphy without using
externalflood source.RadiolOncol.2011;45(3):
184‐8.
8. Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera
GV, Kuerer H, et al. Does blue dye contribute to
successofsentinelnodemappingforbreast
cancer?.AnnSurgOncol.2010;17:280‐5.
9. DangY,EngelJ.Patentbluedyeandanatypical
anaphylactic reaction after sentinel lymph node
biopsy in early breast cancer. Breast J. 2012;18
(1):91‐2.
10. Noirot A, Vigneau A, Salengro A, Bonnet F.
Allergicreactiontopatentbluedyeforsentinel
lymph node detection during uterus oncological
surgery. Ann Fr Anesth Reanim. 2005;24 (5):
541‐2.
11. JangjooA,ShabaniG,ZakaviR,KakhkiVRD,
Sadeghi R. Disappearanceofasentinelnodeon
the delayed lymphoscintigraphy imaging of a
breast cancer patient: Importance of blue dye
injection.Nowotwory.2011;61(1):30‐1.
12. DerossisAM,Fey J,YeungH, YehSD, Heerdt AS,
PetrekJ,etal.Atrendanalysisoftherelative
value of blue dye and isotope localization in
2,000 consecutive cases of sentinel node biopsy
for breast cancer. J Am Coll Surg. 2001;193 (5):
473‐8.